Artificial intelligence used in genome analysis studies

Building and evaluating an artificial intelligence algorithm: A practical guide for practicing oncologists

The use of machine learning and deep learning has enabled many applications, previously thought of as being impossible. Among all medical fields, cancer care is arguably the most significantly impacted, with precision medicine now truly being a possibility. The effect of these technologies, loosely known as artificial intelligence, is particularly striking in fields involving images (such as radiology and pathology) and fields involving large amounts of data (such as genomics). Practicing oncologists are often confronted with new technologies claiming to predict response to therapy or predict the genomic make-up of patients. Underst-anding these new claims and technologies requires a deep understanding of the field. In this review, we provide an overview of the basis of deep learning. We describe various common tasks and their data requirements so that oncologists could be equipped to start such projects, as well as evaluate algorithms presented to them.

Finding and Characterizing Repeats in Plant Genomes

Plant genomes contain a particularly high proportion of repeated structures of various types. This chapter proposes a guided tour of the available software that can help biologists to scan automatically for these repeats in sequence data or check hypothetical models intended to characterize their structures. Since transposable elements (TEs) are a major source of repeats in plants, many methods have been used or developed for this broad class of sequences. They are representative of the range of tools available for other classes of repeats and we have provided two sections on this topic (for the analysis of genomes or directly of sequenced reads), as well as a selection of the main existing software. It may be hard to keep up with the profusion of proposals in this dynamic field and the rest of the chapter is devoted to the foundations of an efficient search for repeats and more complex patterns. We first introduce the key concepts of the art of indexing and mapping or querying sequences. We end the chapter with the more prospective issue of building models of repeat families. We present the Machine Learning approach first, seeking to build predictors automatically for some families of ET, from a set of sequences known to belong to this family. A second approach, the linguistic (or syntactic) approach, allows biologists to describe themselves and check the validity of models of their favorite repeat family.

New Technology Tools and Life Cycle Analysis (LCA) Applied to a Sustainable Livestock Production

Agriculture 4.0, a combination of mechanical innovation and information and communication technologies (ICT) using precision farming, omics technologies and advanced waste treatment techniques, can be used to enhance the biological potential of animal and crop productions and reduce livestock gaseous emissions. In addition to animal proteins being excellent nutritional ingredients for the human diet, there is a growing concern regarding the amount of energy spent converting vegetable crops into animal protein and the relevant environmental impacts. Using the value chain analysis derived from the neoclassic production theory extended to industrial processing and the market, the hypothesis to be tested concerns the sustainability and convenience of different protein sources. The methodology implies the use of life cycle analysis (LCA) to evaluate the efficiency of different livestock diet ingredients. The use of feeding products depend upon various factors, including cost reduction, consumer acceptance, incumbent industry response, civil society support, policy consensus, lower depletion of natural resources, improved sustainable agri-food supply chain and LCA. EU policy makers should be aware of these changes in livestock and market chains and act proactively to encourage the use of alternative animal proteins.

Deep Learning Techniques for Automatic Detection of Embryonic Neurodevelopmental Disorders

The increasing rates of neurodevelopmental disorders (NDs) are threatening pregnant women, parents, and clinicians caring for healthy infants and children. NDs can initially start through embryonic development due to several reasons. Up to three in 1000 pregnant women have embryos with brain defects; hence, the primitive detection of embryonic neurodevelopmental disorders (ENDs) is necessary. Related work done for embryonic ND classification is very limited and is based on conventional machine learning (ML) methods for feature extraction and classification processes. Feature extraction of these methods is handcrafted and has several drawbacks. Deep learning methods have the ability to deduce an optimum demonstration from the raw images without image enhancement, segmentation, and feature extraction processes, leading to an effective classification process. This article proposes a new framework based on deep learning methods for the detection of END. To the best of our knowledge, this is the first study that uses deep learning techniques for detecting END. The framework consists of four stages which are transfer learning, deep feature extraction, feature reduction, and classification. The framework depends on feature fusion. The results showed that the proposed framework was capable of identifying END from embryonic MRI images of various gestational ages. To verify the efficiency of the proposed framework, the results were compared with related work that used embryonic images. The performance of the proposed framework was competitive. This means that the proposed framework can be successively used for detecting END.

Comprehensive Outline of Whole Exome Sequencing Data Analysis Tools Available in Clinical Oncology

Whole exome sequencing (WES) enables the analysis of all protein coding sequences in the human genome. This technology enables the investigation of cancer-related genetic aberrations that are predominantly located in the exonic regions. WES delivers high-throughput results at a reasonable price. Here, we review analysis tools enabling utilization of WES data in clinical and research settings. Technically, WES initially allows the detection of single nucleotide variants (SNVs) and copy number variations (CNVs), and data obtained through these methods can be combined and further utilized. Variant calling algorithms for SNVs range from standalone tools to machine learning-based combined pipelines. Tools for CNV detection compare the number of reads aligned to a dedicated segment. Both SNVs and CNVs help to identify mutations resulting in pharmacologically druggable alterations. The identification of homologous recombination deficiency enables the use of PARP inhibitors. Determining microsatellite instability and tumor mutation burden helps to select patients eligible for immunotherapy. To pave the way for clinical applications, we have to recognize some limitations of WES, including its restricted ability to detect CNVs, low coverage compared to targeted sequencing, and the missing consensus regarding references and minimal application requirements. Recently, Galaxy became the leading platform in non-command line-based WES data processing. The maturation of next-generation sequencing is reinforced by Food and Drug Administration (FDA)-approved methods for cancer screening, detection, and follow-up. WES is on the verge of becoming an affordable and sufficiently evolved technology for everyday clinical use.